These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24339871)

  • 1. Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
    Grande R; Corsi D; Mancini R; Gemma D; Ciancola F; Sperduti I; Rossi L; Fabbri A; Diodoro MG; Ruggeri E; Zampa G; Bianchetti S; Gamucci T
    PLoS One; 2013; 8(12):e80188. PubMed ID: 24339871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative inflammatory response as prognostic factor of patients with colon cancer.
    Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Shoda K; Kosuga T; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Langenbecks Arch Surg; 2019 Sep; 404(6):731-741. PubMed ID: 31468113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
    Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
    J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of treatment for T3N0 colon cancer.
    Yo IS; Opelka FG; Bolton JS; Fuhrman GM
    Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
    Ng K; Ogino S; Meyerhardt JA; Chan JA; Chan AT; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Bertagnolli MM; Venook AP; Fuchs CS
    J Natl Cancer Inst; 2011 Oct; 103(20):1540-51. PubMed ID: 21849660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
    Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Sci Rep; 2019 Aug; 9(1):11846. PubMed ID: 31413354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
    Chibaudel B; Henriques J; Rakez M; Brenner B; Kim TW; Martinez-Villacampa M; Gallego-Plazas J; Cervantes A; Shim K; Jonker D; Guerin-Meyer V; Mineur L; Banzi C; Dewdney A; Dejthevaporn T; Bloemendal HJ; Roth A; Moehler M; Aranda E; Van Cutsem E; Tabernero J; Schmoll HJ; Hoff PM; André T; de Gramont A
    JAMA Netw Open; 2020 Oct; 3(10):e2020425. PubMed ID: 33074326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
    Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.
    Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B
    Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.
    Swanson RS; Compton CC; Stewart AK; Bland KI
    Ann Surg Oncol; 2003; 10(1):65-71. PubMed ID: 12513963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer.
    Nissan A; Protic M; Bilchik AJ; Howard RS; Peoples GE; Stojadinovic A
    Ann Surg; 2012 Sep; 256(3):412-27. PubMed ID: 22871988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
    Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
    J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
    Żok J; Bieńkowski M; Radecka B; Korniluk J; Adamowicz K; Duchnowska R
    BMC Cancer; 2021 May; 21(1):529. PubMed ID: 33971834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
    Baik H; Lee SM; Seo SH; An MS; Kim KH; Bae KB; Oh MK; Hong KH
    ANZ J Surg; 2018 Jun; 88(6):587-591. PubMed ID: 28687025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
    Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
    Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.